| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| 9 METERS BIOPHARMA, INC. | Director | Stock Option (Right to Buy) | 142,509 | $183,837 | $1.29 | 22 Jun 2022 | Direct |
| 9 METERS BIOPHARMA, INC. | Director | Common Stock | 7,885 | $9,541 | $1.21 | 29 Mar 2023 | Direct |
| Notable Labs, Ltd. | Director | Stock Option | 6,534 | 24 Jan 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000106299324001357-rice-yehuda-michael-2024-01-24 | Notable Labs, Ltd. | 24 Jan 2024 | 1 | $0 | 4 | Director | 26 Jan 2024, 11:02 |
| /report/000157856323000013-rice-yehuda-michael-2023-03-29 | 9 METERS BIOPHARMA, INC. | 29 Mar 2023 | 1 | $0 | 4 | Director | 31 Mar 2023, 16:28 |
| /report/000149315223000179-rice-yehuda-michael-2023-01-01 | Vascular Biogenics Ltd. | 01 Jan 2023 | 0 | $0 | 3 | Director | 03 Jan 2023, 20:03 |
| /report/000155198622000060-rice-yehuda-michael-2022-06-22 | 9 METERS BIOPHARMA, INC. | 22 Jun 2022 | 1 | $0 | 4 | Director | 23 Jun 2022, 16:06 |